Evidence map›Paper›PMID 33928637›Full record

ArticleJournal of cellular physiology2021

Regulatory role of TIGAR on endothelial metabolism and angiogenesis.

Xiaochen He, Heng Zeng, Aubrey C Cantrell, Jian-Xiong Chen

Open access · greenAbstract read
In one paragraph

Article in Journal of cellular physiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. TIGAR Deficiency Blunts Angiotensin-II-Induced Cardiac Hypertrophy in Mice.International journal of molecular sciences · 2024
    Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Xiaochen HeDepartment of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi, USA.
Heng ZengDepartment of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi, USA.
Aubrey C CantrellDepartment of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi, USA.
Jian-Xiong ChenDepartment of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi, USA.ORCID 0000-0001-9203-4336
University of Mississippi Medical Center · US

Funding

Regulation of vascular maturation/regression in diabetesR01HL102042 · NHLBI · VANDERBILT UNIVERSITY · PI CHEN, JIAN-XIONG · 2010 to 2020
$3.0M
NHLBI NIH HHS 2R01HL102042NHLBI NIH HHS R01 HL102042
6 · The paper itself

Abstract

Endothelial glycolytic metabolism plays an important role in the process of angiogenesis. TP53-induced glycolysis and apoptosis regulator (TIGAR) is a significant mediator of cellular energy homeostasis. However, the role of TIGAR in endothelial metabolism, angiogenesis, and coronary flow reserve (CFR) has not been studied. The present study investigated whether knockout (KO) of TIGAR improves endothelial glycolytic function and angiogenesis. In vitro, aortic endothelial cells (ECs) from TIGAR KO mice exhibited increased expression of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase isoform-3 (PFKFB3) and increased glycolytic function. These were accompanied by increased mitochondrial basal/maximal respiration and ATP production. Furthermore, knockout of TIGAR in ECs enhanced endothelial proliferation, migration, and tube formation. Knockout of TIGAR also significantly increased aortic sprouting ex vivo. In vivo, knockout of TIGAR increased the expression of proangiogenic factor, angiopoietin-1 (Ang-1) in mouse hearts. Knockout of TIGAR also significantly increased coronary capillary density with enhanced CFR in these hearts. Furthermore, TIGAR KO mice subjected to pressure overload (PO), a common model to study angiogenesis and cardiac hypertrophy, exhibited elevated expression of Ang-1, VEGF, and PFKFB3 than that of the wild-type (WT) mice. WT mice subjected to PO exhibited a significant reduction of coronary capillary density and impaired CFR, but TIGAR KO mice did not. In addition, knockout of TIGAR blunted TAC-induced cardiac hypertrophy and dysfunction seen in the WT mice. In conclusion, knockout of TIGAR improves endothelial angiogenetic capabilities by enhancing the endothelial glycolytic function, mitochondrial respiration, and proangiogenic signaling, which leads to increased coronary capillary density and vascular function and protects against chronic stress.

Indexed as

GlycolysisNeovascularization, PhysiologicAngiopoietin-1AnimalsApoptosis Regulatory ProteinsCardiomegalyCell MovementCell ProliferationCells, CulturedCoronary CirculationCoronary VesselsDisease Models, AnimalEndothelial CellsMaleMiceMice, Inbred C57BLAngiopoietin-1Angpt1 protein, mouseApoptosis Regulatory ProteinsPFKFB3 protein, mousePhosphofructokinase-2Phosphoric Monoester HydrolasesTIGAR protein, mouseVascular Endothelial Growth Factor Avascular endothelial growth factor A, mouseangiogenesiscardiac hypertrophyCFRendothelial glycolysisTIGAR

Identifiers

PMID33928637
PMCPMC10935921
OpenAlexW3158586760

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.